• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风湿热和风湿性心脏病的社区控制:世界卫生组织国际合作项目报告

The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project.

作者信息

Strasser T, Dondog N, El Kholy A, Gharagozloo R, Kalbian V V, Ogunbi O, Padmavati S, Stuart K, Dowd E, Bekessy A

出版信息

Bull World Health Organ. 1981;59(2):285-94.

PMID:6972819
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2396050/
Abstract

The feasibility and effectiveness of a programme for the community control of rheumatic fever and rheumatic heart disease were studied in a cooperative multicentre project initiated and coordinated by the World Health Organization. The programme was carried out in seven centres in various developing countries of Africa, America, and Asia according to a common protocol, and is under way in a further eight countries in Latin America. Pilot community programmes were shown to be practicable and effective in reducing the burden of rheumatic heart disease in developing countries and their extension to cover entire populations should be encouraged.

摘要

在世界卫生组织发起并协调的一项合作多中心项目中,对一项风湿热和风湿性心脏病社区控制计划的可行性和有效性进行了研究。该计划按照共同方案在非洲、美洲和亚洲的不同发展中国家的七个中心开展,并且正在拉丁美洲的另外八个国家实施。试点社区计划已证明在减轻发展中国家风湿性心脏病负担方面切实可行且有效,应鼓励将其推广至覆盖全体人群。

相似文献

1
The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project.风湿热和风湿性心脏病的社区控制:世界卫生组织国际合作项目报告
Bull World Health Organ. 1981;59(2):285-94.
2
WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-90). WHO Cardiovascular Diseases Unit and principal investigators.世界卫生组织在16个发展中国家预防风湿热/风湿性心脏病的规划:第一阶段(1986 - 1990年)报告。世界卫生组织心血管疾病处及主要研究人员
Bull World Health Organ. 1992;70(2):213-8.
3
Rheumatic fever and rheumatic heart disease in developing countries.发展中国家的风湿热和风湿性心脏病
Bull World Health Organ. 1978;56(4):543-50.
4
Prevention of rheumatic fever and rheumatic heart disease in India.印度风湿热和风湿性心脏病的预防
J Assoc Physicians India. 1983 Feb;31(2):95-7.
5
The control of rheumatic fever and rheumatic heart disease: an outline of WHO activities.风湿热和风湿性心脏病的防控:世界卫生组织活动概述
WHO Chron. 1973 Feb;27(2):49-54.
6
Rheumatic fever and rheumatic heart disease in developing countries.发展中国家的风湿热和风湿性心脏病
World Health Forum. 1989;10(2):203-12.
7
Community control of rheumatic heart disease in developing countries: 2. Strategies for prevention and control.发展中国家风湿性心脏病的社区控制:2. 预防与控制策略。
WHO Chron. 1980 Oct;34(10):389-95.
8
Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa?风湿热的一级预防是非洲风湿性心脏病控制中缺失的环节吗?
Circulation. 2009 Aug 25;120(8):709-13. doi: 10.1161/CIRCULATIONAHA.108.836510. Epub 2009 Aug 10.
9
The national programme and the control of rheumatic fever and rheumatic heart disease in two project areas of Thailand.泰国两个项目地区的国家风湿热和风湿性心脏病防治计划
N Z Med J. 1988 Jun 8;101(847 Pt 2):408-10.
10
Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, north Queensland. Establishment of a prophylactic program.昆士兰北部亚拉巴土著社区的风湿热和慢性风湿性心脏病。预防性项目的建立。
Med J Aust. 1993 Mar 1;158(5):316-8.

引用本文的文献

1
Integrating secondary prevention of rheumatic heart disease into the primary healthcare system in Northern Uganda.将风湿性心脏病二级预防纳入乌干达北部的初级卫生保健系统。
BMJ Glob Health. 2025 Aug 22;10(8):e018835. doi: 10.1136/bmjgh-2024-018835.
2
Research priorities for the secondary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report.急性风湿热和风湿性心脏病二级预防和管理的研究重点:美国国立心肺血液研究所研讨会报告。
BMJ Glob Health. 2023 Oct;8(Suppl 9). doi: 10.1136/bmjgh-2023-012468.
3
Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.风湿热和风湿性心脏病连续体的最新进展
Pathogens. 2022 Jan 28;11(2):179. doi: 10.3390/pathogens11020179.
4
The Global Impact of Rheumatic Heart Disease.风湿性心脏病的全球影响。
Curr Cardiol Rep. 2021 Oct 1;23(11):160. doi: 10.1007/s11886-021-01592-2.
5
Burden of Group A Streptococcal Pharyngitis, Rheumatic Fever, and Rheumatic Heart Disease in India: A Systematic Review and Meta-Analysis.印度 A 组链球菌性咽炎、风湿热和风湿性心脏病负担:系统评价和荟萃分析。
Indian J Pediatr. 2022 Jul;89(7):642-650. doi: 10.1007/s12098-021-03845-y. Epub 2021 Aug 11.
6
Throat Colonization and Antibiotic Susceptibility of Group a β-Hemolytic Streptococci Among Rheumatic Heart Disease Patients Attending a Cardiac Referral Hospital in Tanzania, a Descriptive Cross-Sectional Study.坦桑尼亚一家心脏专科医院风湿性心脏病患者中 A 组β溶血性链球菌的咽喉定植及抗生素敏感性:一项描述性横断面研究
Front Surg. 2020 Sep 17;7:57. doi: 10.3389/fsurg.2020.00057. eCollection 2020.
7
Integrating the prevention and control of rheumatic heart disease into country health systems: a systematic review protocol.将风湿性心脏病的预防和控制纳入国家卫生系统:系统评价方案。
BMJ Open. 2019 Jun 22;9(6):e028908. doi: 10.1136/bmjopen-2019-028908.
8
Rheumatic Mitral Stenosis with Incidental Wolff-Parkinson-White Syndrome: A Rare Association. Treated by Percutaneous Transmitral Commissurotomy and Radiofrequency Ablation.风湿性二尖瓣狭窄合并偶发性预激综合征:一种罕见的关联。经皮二尖瓣交界切开术和射频消融治疗。
Heart Views. 2018 Apr-Jun;19(2):58-62. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_42_18.
9
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.A组链球菌、急性风湿热和风湿性心脏病:流行病学与临床考量
Curr Treat Options Cardiovasc Med. 2017 Feb;19(2):15. doi: 10.1007/s11936-017-0513-y.
10
Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.急性风湿热和风湿性心脏病二级预防的依从性:一项系统评价。
Curr Cardiol Rev. 2017;13(2):155-166. doi: 10.2174/1573403X13666170116120828.

本文引用的文献

1
The control of rheumatic fever and rheumatic heart disease: an outline of WHO activities.风湿热和风湿性心脏病的防控:世界卫生组织活动概述
WHO Chron. 1973 Feb;27(2):49-54.